Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[NMO Spectrum Disorders and Anti AQP4 Antibody].
Abnormal brain iron metabolism in irp2 deficient mice is associated with mild neurological and behavioral impairments.
Purine-crosslinked injectable chitosan sponges promote oligodendrocyte progenitor cells' attachment and differentiation.
A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance.
Exploring the role of interleukin-22 in neurological and autoimmune disorders.
Managing Disability in Progressive Multiple Sclerosis.
On the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple Sclerosis.
Injury to a specific neural pathway detected by Ultra-high-field MRI.
Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop.
Regulatory T-cell vaccination independent of auto-antigen.
Hypogeusia as a symptom of neuromyelitis optica spectrum disorder.
Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica.
Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis.
Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis: Recommendations from the International MS Falls Prevention Research Network.
Pathologic heterogeneity persists in early active multiple sclerosis lesions.
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction.
Subclinical Optic Neuritis in Neuromyelitis Optica.
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis.]
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis.
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Pages
« first
‹ previous
…
328
329
330
331
332
333
334
335
336
…
next ›
last »